Literature DB >> 19404563

Hypocholesterolemic effect of Nostoc commune var. sphaeroides Kützing, an edible blue-green alga.

Heather E Rasmussen1, Kara R Blobaum, Elliot D Jesch, Chai Siah Ku, Young-Ki Park, Fan Lu, Timothy P Carr, Ji-Young Lee.   

Abstract

BACKGROUND: Intake of an edible blue-green alga Nostoc commune var. sphaeroides Kützing (N. Commune) has been shown to lower plasma total cholesterol concentration, but the mechanisms behind the hypocholesterolemic effect have not been elucidated. AIM OF THE STUDY: To elucidate the mechanisms underlying the cholesterol-lowering effect of N. commune in mice.
METHODS: Male C57BL/6J mice were fed the AIN-93 M diet supplemented with 0 or 5% (wt/wt) dried N. Commune for 4 weeks. Lipid levels in the plasma and liver, intestinal cholesterol absorption and fecal sterol excretion were measured. Expression of hepatic and intestinal genes involved in cholesterol metabolism was evaluated by quantitative realtime PCR.
RESULTS: N. commune supplementation significantly reduced total plasma cholesterol and triglyceride concentrations by approximately 20% compared to controls. Intestinal cholesterol absorption was significantly decreased, while fecal neutral sterol output was significantly increased in N. commune-fed mice. mRNA levels of the cholesterol transporters such as Niemann Pick C1 Like 1, scavenger receptor class B type 1, ATP-binding cassette transporters G5 and A1 in small intestine were not significantly different between two groups. Hepatic lipid contents including total cholesterol, triglyceride and free cholesterol in N. commune-fed mice were not significantly altered. However, the expression of cholesterol modulating genes including sterol regulatory element binding protein-2 and 3-hydroxy-3-methylglutaryl coenzyme A reductase were significantly increased in mice fed N. commune.
CONCLUSIONS: N. commune supplementation exerted a hypocholesterolemic effect in mice, largely in part, by reducing intestinal cholesterol absorption and promoting fecal neutral sterol excretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404563     DOI: 10.1007/s00394-009-0025-y

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  44 in total

1.  Soluble polysaccharide and biomass of red microalga Porphyridium sp. alter intestinal morphology and reduce serum cholesterol in rats.

Authors:  I Dvir; R Chayoth; U Sod-Moriah; S Shany; A Nyska; A H Stark; Z Madar; S M Arad
Journal:  Br J Nutr       Date:  2000-10       Impact factor: 3.718

Review 2.  Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans.

Authors:  J M Dietschy; S D Turley; D K Spady
Journal:  J Lipid Res       Date:  1993-10       Impact factor: 5.922

3.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

4.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  Spirulina maxima prevents fatty liver formation in CD-1 male and female mice with experimental diabetes.

Authors:  A Rodríguez-Hernández; J L Blé-Castillo; M A Juárez-Oropeza; J C Díaz-Zagoya
Journal:  Life Sci       Date:  2001-07-20       Impact factor: 5.037

6.  Hypocholesterolemic effect of blue-green alga, ishikurage (Nostoc commune) in rats fed atherogenic diet.

Authors:  K Hori; G Ishibashi; T Okita
Journal:  Plant Foods Hum Nutr       Date:  1994-01       Impact factor: 3.921

7.  Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.

Authors:  C D Smith; X Zhang; S L Mooberry; G M Patterson; R E Moore
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

8.  Identification of a receptor mediating absorption of dietary cholesterol in the intestine.

Authors:  H Hauser; J H Dyer; A Nandy; M A Vega; M Werder; E Bieliauskaite; F E Weber; S Compassi; A Gemperli; D Boffelli; E Wehrli; G Schulthess; M C Phillips
Journal:  Biochemistry       Date:  1998-12-22       Impact factor: 3.162

9.  Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population.

Authors:  T A Miettinen; P Puska; H Gylling; H Vanhanen; E Vartiainen
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements.

Authors:  D J Gilroy; K W Kauffman; R A Hall; X Huang; F S Chu
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

View more
  10 in total

1.  Beta-glucan may play an important role in algae hypocholesterolemia effect.

Authors:  Jiezhong Chen; Xu-Feng Huang
Journal:  Eur J Nutr       Date:  2010-02       Impact factor: 5.614

2.  Hypolipidemic Effect of a Blue-Green Alga (Nostoc commune) Is Attributed to Its Nonlipid Fraction by Decreasing Intestinal Cholesterol Absorption in C57BL/6J Mice.

Authors:  Chai Siah Ku; Bohkyung Kim; Tho X Pham; Yue Yang; Curtis L Weller; Timothy P Carr; Young-Ki Park; Ji-Young Lee
Journal:  J Med Food       Date:  2015-07-10       Impact factor: 2.786

3.  In vitro and in vivo safety assessment of edible blue-green algae, Nostoc commune var. sphaeroides Kützing and Spirulina plantensis.

Authors:  Yue Yang; Youngki Park; David A Cassada; Daniel D Snow; Douglas G Rogers; Jiyoung Lee
Journal:  Food Chem Toxicol       Date:  2011-04-05       Impact factor: 6.023

4.  Effects of Long-Term Supplementation of Blue-Green Algae on Lipid Metabolism in C57BL/6J mice.

Authors:  Yue Yang; Bohkyung Kim; Young-Ki Park; Ji-Young Lee
Journal:  J Nutrit Health Food Sci       Date:  2014

Review 5.  Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease.

Authors:  Chai Siah Ku; Yue Yang; Youngki Park; Jiyoung Lee
Journal:  J Med Food       Date:  2013-02       Impact factor: 2.786

6.  Blue-Green Algae Inhibit the Development of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice.

Authors:  Chai Siah Ku; Bohkyung Kim; Tho X Pham; Yue Yang; Casey J Wegner; Young-Ki Park; Marcy Balunas; Ji-Young Lee
Journal:  J Med Food       Date:  2015-11-13       Impact factor: 2.786

7.  Immunomodulatory Potential of the Polysaccharide-Rich Extract from Edible Cyanobacterium Nostoc commune.

Authors:  Hui-Fen Liao; Tai-Jung Wu; Jia-Liang Tai; Meng-Chun Chi; Long-Liu Lin
Journal:  Med Sci (Basel)       Date:  2015-11-04

8.  Anti-Obesity Effect of Nostoc commune Ethanol Extract In Vitro and In Vivo.

Authors:  Sheng-Chieh Tsai; Yu-Wen Huang; Chih-Chung Wu; Jyh-Jye Wang; Ya-Ting Chen; Reeta Rani Singhania; Chiu-Wen Chen; Cheng-Di Dong; Shu-Ling Hsieh
Journal:  Nutrients       Date:  2022-02-24       Impact factor: 5.717

Review 9.  Seafood consumption and components for health.

Authors:  Ryota Hosomi; Munehiro Yoshida; Kenji Fukunaga
Journal:  Glob J Health Sci       Date:  2012-04-28

10.  Egg phospholipids exert an inhibitory effect on intestinal cholesterol absorption in mice.

Authors:  Yoojin Lee; Catherine Y Han; Minkyung Bae; Young-Ki Park; Ji-Young Lee
Journal:  Nutr Res Pract       Date:  2019-06-20       Impact factor: 1.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.